Jaungo showed anti-inflammatory and skin regeneration effects by reducing Immunoglobulin E (IgE), thymus and activation-regulated chemokine (TARC), and interferon-gamma (IFNγ) and inhibiting production of eotaxin for dermatitis. The gene discussed is CCL17; the disease is dermatitis.